CMS innovation center to expand team focused on drug pricesnews2026-03-17T19:07:25+00:00March 17th, 2026|Endpoints News|
Aldeyra dry eye drug gets third rejection from FDA, triggering stock slidenews2026-03-17T18:30:14+00:00March 17th, 2026|Endpoints News|
Drugmakers consider licensing deal tweaks to soften MFN impactnews2026-03-17T16:47:55+00:00March 17th, 2026|Endpoints News|
Rhythm’s Imcivree fails Phase 3 rare form obesity trialnews2026-03-17T13:48:31+00:00March 17th, 2026|Endpoints News|
J&J pulls out of NYC biotech incubator as it shrinks locationsnews2026-03-17T11:00:29+00:00March 17th, 2026|Endpoints News|
Federal judge halts CDC’s childhood vaccine overhaul news2026-03-16T20:37:18+00:00March 16th, 2026|Endpoints News|
BioMarin halts Phase 2 Voxzogo dosing in certain patients over safety concernnews2026-03-16T18:55:04+00:00March 16th, 2026|Endpoints News|
Roivant CEO, bullish on internal growth, dodges M&A chatternews2026-03-13T19:12:27+00:00March 13th, 2026|Endpoints News|
Pfizer to close Ignite, its R&D services unit for small biotechsnews2026-03-12T16:22:55+00:00March 12th, 2026|Endpoints News|
Lilly warns of impurity risk in certain compounded forms of Mounjaro and Zepboundnews2026-03-12T10:53:16+00:00March 12th, 2026|Endpoints News|
